| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 793,784 | 814,743 | 957,173 | 707,836 | | Cost of Revenue | 826,933 | 137,237 | 560,030 | 1,082,420 | | | Gross Profit | (33,149) | 677,506 | 397,143 | (374,584) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (310,317) | 431,210 | 38,807 | (455,720) | | Non Recurring |
-
|
-
|
-
| (63,697) | | Others | 71,268 | 67,221 | 68,511 | 67,446 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 205,900 | 179,075 | 289,825 | 77,387 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,883 | 1,760 | 2,457 | 6,944 | | Earnings Before Interest And Taxes | 207,783 | 180,835 | 292,282 | 84,331 | | Interest Expense | 85,150 | 59,071 | 57,279 | 56,842 | | Income Before Tax | 122,633 | 121,764 | 235,003 | 27,489 | | Income Tax Expense | 45,294 | 48,900 | 100,906 | 11,549 | | Minority Interest | (800) |
-
|
-
| 267 | | | | Net Income From Continuing Ops | 76,539 | 72,864 | 134,097 | 16,207 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 76,539 | 72,864 | 134,097 | 16,207 | | Preferred Stock And Other Adjustments | 428 | (256) | (172) |
-
| | | Net Income Applicable To Common Shares | $76,967 | $72,608 | $133,925 | $16,207 |
|
0.31% Nasdaq 0.00%
Income Statement
